Clinical Trial Update: DNA Methylation Biomarkers for Cervical Cancer Screening

View source ↗

Summary

An investigation into DNA methylation biomarkers for cervical cancer screening. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Snippet

Sponsor: iStat Biomedical CO., Ltd. | Conditions: Cervical Intraepithelial Neoplasia, Cervical Cancer | Status: UNKNOWN